Araneta, Michael Ian M.

HRN: 21-89-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFTRIAXONE 1G (VIAL)
09/18/2022
09/26/2022
IV
2 Grams
Q24h
T/c CAP-MR, Presumptive PTB
Waiting Final Action 
09/18/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/18/2022
09/26/2022
IV
2 Grams
Q24h
T/c CAP-MR, Presumptive PTB
Waiting Final Action 
09/19/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/19/2022
09/26/2022
IV
1.5gms
Q6
Empirical Escalation
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: